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Shared treatment decision-making (tdm) is the process by which physicians and patients make treatment decisions by sharing 
information, expressing preferences and agreeing to 
implement a proposed treatment.1 Among patients 
who are diagnosed with life-threatening diseases 
such as cancer, shared TDM has been associated with 
improved physical and psychological health outcomes, 
greater patient compliance with regards to oncological 
treatments, higher levels of patient satisfaction and 
reduced overall healthcare costs.2,3 Indeed, it has been 
observed that the majority of cancer patients prefer 
having a role in TDM along with their physicians; 
however, there is controversy regarding the appropriate 
level of involvement of patients’ families.4,5
In an online survey of 290 middle-aged urban 
residents, Alden et al. found that individuals who 
preferred to be more involved in TDM—either as 
shared or autonomous TDM—tended to prefer less 
family involvement for a variety of illnesses ranging 
in severity, particularly if the family member in 
question was young.5 Interestingly, this study included 
samples from many Eastern countries, including 
China, Thailand, South Korea, Malaysia and India; 
this finding also held in those countries, as well as 
in the USA and Australia.5 Another study found that 
poor South Korean patients preferred autonomous 
TDM for end-of-life decisions, as they were often 
concerned that younger relatives might more heavily 
weigh financial concerns versus the patient’s own 
preferences.6 Researchers in the Asian Pacific region 
have therefore concluded that there are meaningful 
segments of patients across very different cultures 
who prefer little or no family involvement in TDM 
and higher levels of shared and autonomous TDM.5,6 
In another study of patient-caregiver dyads in Korea, 
most patients and caregivers valued and expected 
family involvement in TDM; however, there was little 
explicit agreement regarding which party in the dyad 
should take decisional leadership and which should 
play a supporting role.7
Several studies have shown that cancer patients 
and their family members prefer family participation 
in TDM to some extent.7–9 Among patients with 
advanced lung cancer in Belgium, Pardon et al. 
reported that patients’ family members regularly 
attended consultation and treatment appointments in 
order to provide emotional support, request further 
information and participate in the TDM process.10 A 
large, multiregional, prospective cohort study of newly 
diagnosed patients with lung and colorectal cancer 
undertaken in the USA found that most participants 
involved family members in treatment decisions.11 
Nevertheless, the study concluded that further research 
is required to evaluate the impact such involvement 
might have on patient outcomes. The authors also 
noted that physicians should consider determining 
the patients’ preferences regarding family involvement 
at the outset of care.11 In Oman, many breast cancer 
patients were found to rely on their families for 
emotional, physical and financial support, the absence 
of which negatively affected the patient’s prognosis.12 It 
should be noted that the impact of a cancer diagnosis 
on family members is sometimes similar to that of the 
patient in terms of stress, depression, anxiety, financial 
constraints and interpersonal problems.13,14
In Eastern countries, patients are more likely to 
be guided by their families during the TDM process, 
which is often associated with high levels of positive 
emotional engagement, and are therefore less likely 
to make key medical decisions.15 Family members in 
such countries tend to believe that TDM should lie 
in the hands of the patient’s family members and that 
these individuals should be involved directly in the 
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TDM process, perhaps due to a strong sense of moral 
responsibility.7,16 In certain Middle Eastern, North 
African and South Asian societies, the family has final 
authority in TDM, as often the patient is inseparably 
linked to the family as a whole.17 For example, the 
majority of cancer patients in South Korea preferred 
shared TDM with their family members, although it 
was noted that there may be disagreements between 
family members and patients.7 
In a study from Pakistan, family members 
sometimes met the physician independently and 
gave consent for treatment on the patient’s behalf.18 
Furthermore, physicians of cancer patients in China 
and Japan actually preferred to consult primarily with 
family members, giving these individuals the authority 
to decide whether to involve the patient in the TDM 
process at all.15,19 In Oman, some oncologists have 
noted that family members play a significant role in 
the TDM process, sometimes to the extent that the 
patient loses their autonomy; this can delay treatment 
and even affect survival.20 Another study found that, in 
some Arabic countries, male family members held the 
dominant role in the TDM process, particularly if the 
patient was female.21 
Nevertheless, while most cancer patients seem to 
prefer family involvement in the TDM process, many 
physicians in Western countries have raised concerns 
regarding the potential loss of patient autonomy when 
family members become involved in treatment.8 In 
such countries, the individual rights of cancer patients 
are respected and protected by physicians; therefore, 
family members retain only limited powers when it 
comes to intervening in medical care, particularly in 
cases wherein the patient is deemed competent enough 
to make their own decisions.14,16 However, physicians 
may sometimes encounter family members who ask 
them not to involve the patient in the TDM process or 
even, in some cases, not to inform the patient of their 
diagnosis at all.22 
Although many physicians welcome varying 
levels of family involvement in TDM, most families 
are naturally cautious of challenging the physician’s 
professional authority and intervening with the patient’s 
treatment.23 Some physicians could react negatively to 
family members’ requests if they believe them to be 
in breach of the patient’s dignity and/or autonomy. 
Indeed, medical law in many Western countries states 
that, in the majority of circumstances, the patients 
themselves have the final decision with regards to 
TDM.17 However, the cultural background of the 
physicians may influence their response to involving 
family members in the TDM process. One study 
conducted in the USA showed that the majority of 
physicians of Japanese heritage would obey a family’s 
request not to involve the cancer patient in TDM while 
very few North American physicians would consent to 
this request.24 
In Western countries, the concept of relational 
autonomy, which considers the individualistic per-
ception of autonomy within a larger social framework, 
allows for the inclusion of family members in the TDM 
process.17 Thus, physicians are requested to abide by 
their patients’ expressed wishes with regards to family 
involvement in TDM and to consider the family’s 
opinions during care, in the absence of any evidence of 
abuse or neglect.23 Nevertheless, research conducted 
in the UK indicated that while the relatives of cancer 
patients influenced the decision-making process itself, 
the final decision was ultimately left to the patient.25 
Similarly, most Australian physicians reported positive 
attitudes towards family involvement in TDM, but had 
concerns regarding a number of challenges which can 
arise when family members are involved in TDM, 
although the overall benefits of familial involvement 
were found to outweigh the costs.26 Therefore, while 
family involvement in decision-making is often apprec- 
iated, preferences for the nature and extent of their 
involvement may vary based on other influencing 
factors. As such, it may be beneficial if physicians 
ascertain individual patients’ preferences and remain 
open-minded regarding the various ways that the 
patient’s family can be involved.
In summary, TDM in cancer cases is complex, as 
it involves the patient, the patient’s family members 
and physicians, with each stakeholder potentially 
having a different opinion regarding the patient’s 
medical needs. When it comes to the degree of 
acceptance of familial involvement, it seems that the 
most important factor is not the specific location 
but the cultural background of those involved. While 
individuals from Western cultures perceive that the 
patient’s dignity and autonomy must be protected 
above all, family members of Eastern cultures may 
not necessarily agree. Further understanding of the 
differences between Western and Eastern cultures is 
needed. Moreover, the concept of relational autonomy 
does not take into consideration the cultural 
background of the patient or allow family members 
any legal authority. As such, new legislation may 
need to be proposed, should family members wish to 
become more involved in the TDM process in certain 
countries. However, it is vital that such involvement 
be considered only in agreement with the patient’s 
wishes as evidenced by a recorded conversation with 
the provider present, or a legal document (i.e. a power 
of attorney or advanced legal directive) that specifies 
the conditions under which the patient desires their 
family be involved in the TDM process.
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